Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China.
about
Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysisTelbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysis.Quality of pharmacoeconomic research in China: A systematic reviewAnnual economic burden of hepatitis B virus-related diseases among hospitalized patients in twelve cities in China.Cost-Effectiveness of Peg-Interferon, Interferon and Oral Nucleoside Analogues in the Treatment of Chronic Hepatitis B and D Infections in China.
P2860
Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cost-effectiveness analysis of ...... chronic hepatitis B in China.
@ast
Cost-effectiveness analysis of ...... chronic hepatitis B in China.
@en
Cost-effectiveness analysis of ...... chronic hepatitis B in China.
@nl
type
label
Cost-effectiveness analysis of ...... chronic hepatitis B in China.
@ast
Cost-effectiveness analysis of ...... chronic hepatitis B in China.
@en
Cost-effectiveness analysis of ...... chronic hepatitis B in China.
@nl
prefLabel
Cost-effectiveness analysis of ...... chronic hepatitis B in China.
@ast
Cost-effectiveness analysis of ...... chronic hepatitis B in China.
@en
Cost-effectiveness analysis of ...... chronic hepatitis B in China.
@nl
P2093
P2860
P356
P1476
Cost-effectiveness analysis of ...... chronic hepatitis B in China.
@en
P2093
Huafeng Cheng
Jinfang Shen
P2860
P2888
P356
10.1186/1472-6963-12-385
P577
2012-11-08T00:00:00Z
P5875
P6179
1048558987